$188.64
In chiusura: Oct 6 EDT
$188.07
-0.57-0.30%
Pre-mercato: 6:09 AM EDT
Johnson & Johnson segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Analizza lo storico degli utili di Johnson & Johnson utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
JNJ | Johnson & Johnson | $2.42 | $2.76 | — | — | $22.47B | $23.73B | — | — | 10/14/2025 | |
JNJ | Johnson & Johnson | $2.82 | $2.67 | $2.77 | 3.75% | $22.45B | $22.83B | $23.74B | 3.98% | 07/16/2025 | |
JNJ | Johnson & Johnson | $2.71 | $2.60 | $2.77 | 6.54% | $21.38B | $21.57B | $21.89B | 1.50% | 04/15/2025 | |
JNJ | Johnson & Johnson | $2.29 | $2.02 | $2.04 | 0.99% | $21.39B | $22.45B | $22.52B | 0.31% | 01/22/2025 | |
JNJ | Johnson & Johnson | $2.66 | $2.21 | $2.42 | 9.50% | $21.35B | $22.16B | $22.47B | 1.40% | 10/15/2024 | |
JNJ | Johnson & Johnson | $2.56 | $2.70 | $2.82 | 4.44% | $21.52B | $22.31B | $22.45B | 0.61% | 07/17/2024 | |
JNJ | Johnson & Johnson | $2.41 | $2.64 | $2.71 | 2.65% | $20.89B | $21.41B | $21.38B | -0.13% | 04/16/2024 | |
JNJ | Johnson & Johnson | $2.05 | $2.28 | $2.29 | 0.44% | $23.71B | $20.99B | $21.39B | 1.93% | 01/23/2024 | |
JNJ | Johnson & Johnson | $2.23 | $2.51 | $2.66 | 5.98% | $20.00B | $21.04B | $21.35B | 1.48% | 10/17/2023 | |
JNJ | Johnson & Johnson | $2.59 | $2.62 | $2.80 | 6.87% | $24.02B | $24.63B | $25.53B | 3.65% | 07/20/2023 | |
JNJ | Johnson & Johnson | $2.67 | $2.51 | $2.68 | 6.77% | $23.43B | $23.67B | $24.75B | 4.55% | 04/18/2023 | |
JNJ | Johnson & Johnson | $2.13 | $2.23 | $2.35 | 5.38% | $24.80B | $23.94B | $23.71B | -0.98% | 01/24/2023 | |
JNJ | Johnson & Johnson | $2.60 | $2.52 | $2.55 | 1.19% | $23.34B | $23.47B | $23.79B | 1.37% | 10/18/2022 | |
JNJ | Johnson & Johnson | $2.48 | $2.57 | $2.59 | 0.78% | $23.32B | $23.81B | $24.02B | 0.88% | 07/19/2022 | |
JNJ | Johnson & Johnson | $2.59 | $2.61 | $2.67 | 2.30% | $22.32B | $23.67B | $23.43B | -1.03% | 04/19/2022 | |
JNJ | Johnson & Johnson | $1.86 | $2.12 | $2.13 | 0.47% | $22.48B | $25.29B | $24.80B | -1.92% | 01/25/2022 | |
JNJ | Johnson & Johnson | $2.20 | $2.36 | $2.60 | 10.17% | $21.08B | $23.74B | $23.34B | -1.69% | 10/19/2021 | |
JNJ | Johnson & Johnson | $1.67 | $2.27 | $2.48 | 9.25% | $18.34B | $22.19B | $23.32B | 5.10% | 07/21/2021 | |
JNJ | Johnson & Johnson | $2.30 | $2.34 | $2.59 | 10.68% | $20.69B | $22.01B | $22.32B | 1.41% | 04/20/2021 | |
JNJ | Johnson & Johnson | $1.88 | $1.82 | $1.86 | 2.20% | $20.75B | $21.67B | $22.48B | 3.71% | 01/26/2021 | |
JNJ | Johnson & Johnson | $2.12 | $1.98 | $2.20 | 11.11% | $20.73B | $20.20B | $21.08B | 4.37% | 10/13/2020 |
Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
---|---|---|---|---|
Q2 | 2025-07-16 | $2.77 | $2.67 | 3.75 % |
Q1 | 2025-04-15 | $2.77 | $2.60 | 6.54 % |
Q4 | 2025-01-22 | $2.04 | $2.02 | 0.99 % |
Q3 | 2024-10-15 | $2.42 | $2.21 | 9.50 % |
Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
---|---|---|---|---|
Q2 | 2025-07-16 | $23.74B | $22.83B | 3.98 % |
Q1 | 2025-04-15 | $21.89B | $21.57B | 1.50 % |
Q4 | 2025-01-22 | $22.52B | $22.45B | 0.31 % |
Q3 | 2024-10-15 | $22.47B | $22.16B | 1.40 % |
Si prevede che Johnson & Johnson (JNJ) fornisca risultati il ottobre 14, 2025. Gli ultimi risultati sono stati pubblicati il luglio 16, 2025 per il Q2.
L'EPS effettivo era $2.77, che superato la stima di $2.67.
Le entrate effettive sono state $23.7B, che superato la stima di $22.8B.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.